Tenet Healthcare (NYSE:THC) Updates FY 2026 Earnings Guidance

Tenet Healthcare (NYSE:THC) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 20.300-21.690 for the period, compared to the consensus estimate of 17.810. The company issued revenue guidance of $21.9 billion-$22.5 billion, compared to the consensus revenue estimate of $22.0 billion.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on THC shares. Barclays upped their price objective on Tenet Healthcare from $238.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, July 8th. KeyCorp cut their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Stephens decreased their price objective on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. TD Cowen dropped their target price on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Finally, Weiss Ratings downgraded Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 2nd. Seventeen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $244.84.

Tenet Healthcare Price Performance

Shares of NYSE:THC traded up $4.50 on Thursday, hitting $199.85. The company had a trading volume of 1,728,933 shares, compared to its average volume of 1,246,234. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The company has a market cap of $17.22 billion, a PE ratio of 10.39, a PEG ratio of 1.63 and a beta of 1.27. Tenet Healthcare has a 52-week low of $146.60 and a 52-week high of $247.21. The business has a 50 day moving average of $184.41 and a 200 day moving average of $197.37.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company had revenue of $5.63 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities analysts anticipate that Tenet Healthcare will post 17.5 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Tenet Healthcare news, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nadja West sold 3,000 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director directly owned 24,805 shares in the company, valued at approximately $4,399,166.75. This represents a 10.79% decrease in their position. The SEC filing for this sale provides additional information. 0.97% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tenet Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of THC. Sivia Capital Partners LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $290,000. GeoWealth Management LLC purchased a new position in shares of Tenet Healthcare in the 4th quarter worth $92,000. Magnolia Capital Advisors LLC acquired a new position in Tenet Healthcare in the fourth quarter valued at $203,000. AlphaCentric Advisors LLC purchased a new stake in Tenet Healthcare during the fourth quarter valued at about $104,000. Finally, Jacobs Levy Equity Management Inc. purchased a new position in shares of Tenet Healthcare in the 3rd quarter worth about $206,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.